Related references
Note: Only part of the references are listed.Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
Chen Lossos et al.
CANCER DISCOVERY (2019)
CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models
Bjarne Bogen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
CD4+ T-cell-Mediated Rejection of MHC Class II-Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
Ole Audun W. Haabeth et al.
CANCER RESEARCH (2018)
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
Michael S. Khodadoust et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Prognostic value of diametrically polarized tumor- associated macrophages in multiple myeloma
Xinyi Chen et al.
ONCOTARGET (2017)
Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma
S. Panchabhai et al.
LEUKEMIA (2016)
Idiotype-specific CD4+ T cells eradicate disseminated myeloma
O. A. Haabeth et al.
LEUKEMIA (2016)
Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens
Anders Aune Tveita et al.
CANCER RESEARCH (2015)
Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival
Caroline M. Reed et al.
CLINICAL CANCER RESEARCH (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Indirect CD4+ T-cell-mediated elimination of MHC IINEG tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells
Anders A. Tveita et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
How do CD4+ T cells detect and eliminate tumor cells that either lack or express MHC class II molecules?
Ole Audun Werner Haabeth et al.
FRONTIERS IN IMMUNOLOGY (2014)
Limitations of bystander killing in Th1/M1 immune responses against a secreted tumor antigen
Anders Aune Tveita et al.
ONCOIMMUNOLOGY (2014)
Tumor-associated macrophages as a prognostic parameter in multiple myeloma
Elif Suyani et al.
ANNALS OF HEMATOLOGY (2013)
Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
Simona Berardi et al.
JOURNAL OF ONCOLOGY (2013)
Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice
Kristina Berg Lorvik et al.
BLOOD (2012)
Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
Jaehyup Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease
Peter O. Hofgaard et al.
PLOS ONE (2012)
A model for cancer-suppressive inflammation
Ole Audun Werner Haabeth et al.
ONCOIMMUNOLOGY (2012)
M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
Moniek Heusinkveld et al.
JOURNAL OF IMMUNOLOGY (2011)
Is Secretion of Tumour-specific Antigen Important for Cancer Eradication by CD4+ T Cells? - Implications for Cancer Immunotherapy by Adoptive T Cell Transfer
A. Corthay et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
Ole Audun Werner Haabeth et al.
NATURE COMMUNICATIONS (2011)
Bystander killing of cancer requires the cooperation of CD4+ and CD8+ T cells during the effector phase
Andrea Schietinger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
Yuhuan Zheng et al.
BLOOD (2009)
Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells
Alexandre Corthay et al.
CANCER RESEARCH (2009)
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice
Jean M. Daley et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
Primary antitumor immune response mediated by CD4+ T cells
A Corthay et al.
IMMUNITY (2005)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies
KU Lundin et al.
BLOOD (2003)
Essential and instructive roles of GATA factors in eosinophil development
R Hirasawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNγ receptor expression by nonhematopoietic cells
ZH Qin et al.
IMMUNITY (2000)
Share Paper
